Get the Latest Global and China Market Research Reports by AskLinker

In-depth analysis, competitive scenario, trends, forecasts and more

Ask Linker Reports
The Blood Testing Market to Be Driven By Technical Developments
Published : 2016-09-26

An intact and sufficient blood supply is indispensable to the healthcare industry. New developments, predominantly in the area of computerization, have boosted both safety and blood accessibility. In the past few years, many companies have launched numerous next-generation merchandises to substitute almost all the previous generation systems.

Blood testing is a laboratory-based examination of the blood that helps decide the complete state of the healthiness of an individual. Blood testing can be also identify the occurrence of bacteria and virus and evaluate the growth of a disease and can help in detecting major health problems like HIV/AIDS, diabetes, cardiovascular diseases, anemia, and cancer. Blood testing is often suggested by doctors for evaluating the regular functioning of the body. It is also implemented to investigate the functioning of the key organs of the body such as thyroid, liver, and kidney.

The innovative computerized systems, which are totally automatic, can process numerous test samples per hour. For instance, automation has enhanced the donation practice. Usually, donors give a single unit of red blood cells by means of manual techniques. But new expertise makes it feasible for the gathering of two units of red cells from a single donation by a process called double red cell apheresis. Disease screening and Blood typing have also profited from automation.

Without a doubt, current advances in safety testing and quality guarantee of blood and plasma also have affected the market. These serious developments comprise integration of genetic engineering methods to make human serum albumin and recombinant clotting factors, new means of handling blood, and the innovation of other specialized blood cells like stem cells and dendritic cells.

The global blood testing market is motivated by the rising elderly population. An upsurge in the occurrence of thyroid, HIV, cancer, and genetic disorders is boosting the market for blood testing globally. The presence of numerous bacterial and viral allergic ailments is also contributing to a growth in the sum of blood tests universally. The mounting demand for point of care testing (POCT) is likely to benefit the blood testing market. Technical innovations resultant in the improvement of ground-breaking testing tools and equipment will further boost the market. Developing implementation of testing and screening procedures that augment near patient diagnosis via improved blood testing that diminish diagnostic turnaround times and lessen hospitals stay periods is a key factor anticipated to offer profitable growth in demand for the market.

Growing pools of patient alertness that have been observed in numerous demographic sections across developed and developing economies alike is one more outstanding factor projected to drive growth. Increasing occurrence of prolonged diseases such as diabetes, that require long term disease management is also a substantial element contributing to the growth of the global blood testing market.

North America headed the blood testing market in the past few years and is projected to retain its leading role over the market in the forthcoming years. Europe is estimated to be the second largest regional market in the near future. Nevertheless, Asia Pacific is estimated to be the swiftest growing regional segment in the coming years, with India, Japan, Australia, and China being the most budding markets. 

Read more on Medical Market

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy